Literature DB >> 25273350

Open Payments goes live with pharma to doctor fee data: first analysis.

Duncan Jarvies, Rebecca Coombes, Will Stahl-Timmins.   

Abstract

Mesh:

Year:  2014        PMID: 25273350     DOI: 10.1136/bmj.g6003

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data.

Authors:  Andre M Samuel; Matthew L Webb; Adam M Lukasiewicz; Daniel D Bohl; Bryce A Basques; Glenn S Russo; Vinay K Rathi; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2015-06-19       Impact factor: 4.176

Review 2.  Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program.

Authors:  Deborah C Marshall; Madeleine E Jackson; Jona A Hattangadi-Gluth
Journal:  Mayo Clin Proc       Date:  2016-01       Impact factor: 7.616

3.  Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.

Authors:  Hiroaki Saito; Akihiko Ozaki; Toyoaki Sawano; Yuki Shimada; Tetsuya Tanimoto
Journal:  JAMA Netw Open       Date:  2019-04-05

4.  Impact of US industry payment disclosure laws on payments to surgeons: a natural experiment.

Authors:  Taeho Greg Rhee; Tijana Stanic; Joseph S Ross
Journal:  Res Integr Peer Rev       Date:  2020-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.